Latest filing published 14 Sept 2017 for Bio-Rad Laboratories, INC., €59k.
Filing timeline
BuySaleInsider track record
John Goetz: trading record in brief
John Goetz discloses dealings in Bio-Rad Laboratories, Inc. to SEC (Form 4). Between 1 August 2007 and 13 September 2017, the trades on record add up to 87 filings.
The open-market record consists of 11 sales worth €3.9M, with no purchase. Besides market trades, the filings include 23 share grants and 53 option exercises. So far in 2017, the count stands at no purchases and 2 sales.
On 14 September 2017 came the latest disclosure, a share grant for €92k in Bio-Rad Laboratories, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Goetz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 650 shares@ US$107.320.7% of flowBio-Rad A Common StockSEC:0001652252-17-000106:0
- 491 shares@ US$220.471.1% of flowBio-Rad A Common StockSEC:0001652252-17-000106:1
- 640 shares@ US$117.000.7% of flowBio-Rad A Common StockSEC:0001652252-17-000106:2
- 497 shares@ US$220.471.1% of flowBio-Rad A Common StockSEC:0001652252-17-000106:3
- 1,200 shares@ US$119.541.4% of flowBio-Rad A Common StockSEC:0001652252-17-000106:4
- 938 shares@ US$220.472.0% of flowBio-Rad A Common StockSEC:0001652252-17-000106:5
- 1,600 shares@ US$139.562.2% of flowBio-Rad A Common StockSEC:0001652252-17-000106:6
- 1,320 shares@ US$220.472.9% of flowBio-Rad A Common StockSEC:0001652252-17-000106:7
- 1,600 shares@ US$159.322.5% of flowBio-Rad A Common StockSEC:0001652252-17-000106:8
- 1,388 shares@ US$220.473.0% of flowBio-Rad A Common StockSEC:0001652252-17-000106:9
- 157 shares@ US$218.040.3% of flowBio-Rad A Common StockSEC:0001652252-17-000096:1
- 300 shares0Bio-Rad A Common StockSEC:0001652252-17-000096:0
- 992 shares@ US$218.862.1% of flowBio-Rad A Common StockSEC:0001652252-17-000078:3
- 627 shares@ US$218.421.3% of flowBio-Rad A Common StockSEC:0001652252-17-000078:1
- 1,200 shares0Bio-Rad A Common StockSEC:0001652252-17-000078:0
- 1,900 shares0Bio-Rad A Common StockSEC:0001652252-17-000078:2
- 835 shares@ US$215.441.8% of flowBio-Rad A Common StockSEC:0001652252-17-000062:1
- 1,600 shares0Bio-Rad A Common StockSEC:0001652252-17-000062:0
- 2,600 shares@ US$107.322.8% of flowBio-Rad A Common StockSEC:0001315406-17-000014:0
- 1,978 shares@ US$215.004.2% of flowBio-Rad A Common StockSEC:0001315406-17-000014:1
- 1,920 shares@ US$117.002.2% of flowBio-Rad A Common StockSEC:0001315406-17-000014:2
- 1,502 shares@ US$215.003.2% of flowBio-Rad A Common StockSEC:0001315406-17-000014:3
- 2,400 shares@ US$119.542.9% of flowBio-Rad A Common StockSEC:0001315406-17-000014:4
- 1,891 shares@ US$215.004.1% of flowBio-Rad A Common StockSEC:0001315406-17-000014:5
- 1,600 shares@ US$139.562.2% of flowBio-Rad A Common StockSEC:0001315406-17-000014:6
25 of 87 declarations
